Biohaven Ltd.
US ˙ NYSE ˙ VGG1110E1079

SecurityBHVN / Biohaven Ltd.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in BHVN / Biohaven Ltd.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Biohaven Ltd. (US:BHVN) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,946 shares of Biohaven Ltd.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BIOHAVEN LTD COM COM G1110E107 0 -100.00 0
2026-02-05 2025-12-31 13F BIOHAVEN LTD COM COM G1110E107 2,946 7 0.24 0 0.0002
2025-10-29 2025-09-30 13F BIOHAVEN LTD COM COM G1110E107 2,939 0 0.00 0 0.0003
2025-08-04 2025-06-30 13F BIOHAVEN LTD COM COM G1110E107 2,939 0 0.00 0 0.0003
2025-04-25 2025-03-31 13F BIOHAVEN LTD COM COM G1110E107 2,939 10 0.34 0 0.0006
2025-02-04 2024-12-31 13F BIOHAVEN LTD COM COM G1110E107 2,929 527 21.94 0 0.0009
2024-10-30 2024-09-30 13F BIOHAVEN LTD COM COM G1110E107 2,402 0 0.00 0 0.0010
2024-08-12 2024-06-30 13F BIOHAVEN LTD COM COM G1110E107 2,402 68 2.91 0 0.0007
2024-04-23 2024-03-31 13F BIOHAVEN LTD COM COM G1110E107 2,334 -3,787 -61.87 0 0.0011
2024-02-06 2023-12-31 13F BIOHAVEN LTD COM COM G1110E107 6,121 195 3.29 0 0.0021
2023-11-08 2023-09-30 13F BIOHAVEN LTD COM COM G1110E107 5,926 0 0.00 0 0.0013
2023-08-11 2023-06-30 13F BIOHAVEN LTD COM COM G1110E107 5,926 -2,147 -26.59 0 0.0011
2023-05-02 2023-03-31 13F BIOHAVEN LTD COM COM G1110E107 8,073 -1,590 -16.45 0 0.0009
2023-02-10 2022-12-31 13F BIOHAVEN LTD COM COM G1110E107 9,663 226 2.39 0 -100.00 0.0012
2022-11-09 2022-09-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 9,437 245 2.67 1,427 6.57 0.0138
2022-08-15 2022-06-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 9,192 863 10.36 1,339 35.53 0.0125
2022-08-25 2022-03-31 13F/A-1 BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 8,329 -624 -6.97 988 -19.94 0.0077
2022-06-30 2022-03-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 8,329 -624 988 0.0078
2022-02-15 2021-12-31 13F/A-1 BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 8,953 -88 -0.97 1,234 -1.75 0.0091
2022-02-15 2021-12-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 8,953 -88 1,234 0.0091
2021-10-29 2021-09-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 9,041 -306 -3.27 1,256 38.48 0.0106
2021-08-16 2021-06-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 9,347 2,497 36.45 907 93.80 0.0073
2021-05-13 2021-03-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 6,850 -668 -8.89 468 -27.33 0.0175
2021-02-12 2020-12-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 7,518 40 0.53 644 32.51 0.0244
2020-10-30 2020-09-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 7,478 -71 -0.94 486 -11.96 0.0211
2020-08-10 2020-06-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 7,549 182 2.47 552 119.92 0.0255
2020-05-13 2020-03-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 7,367 198 2.76 251 -35.64 0.0061
2020-02-13 2019-12-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 7,169 615 9.38 390 42.86 0.0072
2019-11-13 2019-09-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 6,554 588 9.86 273 4.60 0.0057
2019-08-14 2019-06-30 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 5,966 1,252 26.56 261 7.41 0.0061
2019-05-15 2019-03-31 13F BIOHAVEN PHARMACEUTICAL HOLDING COM G11196105 4,714 4,714 243 0.0059
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.